Meritain Eldorado policies
Search Meritain Eldorado's public medical, payment and drug policies by CPT or HCPCS code, keyword or policy number, with links to the payer's own documents. Links open the payer's own document; check its current version before relying on it.
8 policies name J9071, those listing the fewest codes first. A policy that names a code may also list it as excluded.
| Policy | Details | Codes | Source |
|---|---|---|---|
| 0940-Mogamulizumab-kpkc (Poteligeo) | 0940 · Commercial | 19 | Original policy ↗ |
| 0919-Inotuzumab Ozogamicin (Besponsa) | 0919 · Commercial | 22 | Original policy ↗ |
| 0867-Clofarabine | 0867 · Commercial | 32 | Original policy ↗ |
| 0955-Polatuzumab vedotin-piiq (Polivy) | 0955 · Commercial | 34 | Original policy ↗ |
| 0845-Carfilzomib (Kyprolis) | 0845 · Commercial | 38 | Original policy ↗ |
| 0904-Daratumumab (Darzalex) and Daratumumab and Hyaluronidase-fihj (Darzalex Faspro) | 0904 · Commercial | 39 | Original policy ↗ |
| 0823-Brentuximab Vedotin (Adcetris) | 0823 · Commercial | 47 | Original policy ↗ |
| 0877-Obinutuzumab (Gazyva) | 0877 · Commercial | 52 | Original policy ↗ |